Latest Breaking News On - Volitionrx limited - Page 1 : vimarsana.com

VolitionRx (NYSE:VNRX) Receives New Coverage from Analysts at StockNews com

StockNews.com initiated coverage on shares of VolitionRx (NYSE:VNRX – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the stock. Separately, Cantor Fitzgerald reissued an overweight rating and issued a $2.50 price target on shares of VolitionRx in a report on Thursday, May 16th. Get […]

United statesSilverberg bernstein capital managementExchange commissionVolitionrx limitedCantor fitzgeraldFree reportGet free reportBernstein capital managementVolitionrx daily

VolitionRx (NYSE:VNRX) Coverage Initiated at StockNews com

Equities research analysts at StockNews.com started coverage on shares of VolitionRx (NYSE:VNRX – Get Free Report) in a report issued on Tuesday. The brokerage set a “sell” rating on the stock. Separately, Cantor Fitzgerald restated an “overweight” rating and issued a $2.50 price objective on shares of VolitionRx in a report on Thursday, May 16th. […]

United statesSilverberg bernstein capital managementVolitionrx company profileCantor fitzgeraldVolitionrx limitedGet free reportBernstein capital managementFree reportVolitionrx daily

StockNews com Begins Coverage on VolitionRx (NYSE:VNRX)

StockNews.com assumed coverage on shares of VolitionRx (NYSE:VNRX – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the stock. Separately, Cantor Fitzgerald reaffirmed an overweight rating and set a $2.50 target price on shares of VolitionRx in a research report on Thursday, May 16th. Get […]

United statesExchange commissionVolitionrx limitedSilverberg bernstein capital managementVolitionrx company profileCantor fitzgeraldFree reportGet free reportBernstein capital managementVolitionrx daily

VolitionRx (NYSE:VNRX) Receives New Coverage from Analysts at StockNews com

StockNews.com assumed coverage on shares of VolitionRx (NYSE:VNRX – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock. Separately, Cantor Fitzgerald reaffirmed an overweight rating and set a $2.50 price objective on shares of VolitionRx in a research note on Wednesday, March 27th. […]

United statesCantor fitzgeraldSilverberg bernstein capital managementVolitionrx company profileVolitionrx limitedFree reportGet free reportBernstein capital managementVolitionrx daily

Cantor Fitzgerald Reiterates Overweight Rating for VolitionRx (NYSE:VNRX)

Cantor Fitzgerald Reiterates Overweight Rating for VolitionRx (NYSE:VNRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesSilverberg bernstein capital managementCantor fitzgeraldVolitionrx limitedGet free reportBernstein capital managementFree reportVolitionrx daily